Matches in Wikidata for { <http://www.wikidata.org/entity/Q91205714> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91205714 description "article scientifique publié en 2019" @default.
- Q91205714 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91205714 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91205714 description "scientific article published on 06 November 2019" @default.
- Q91205714 description "wetenschappelijk artikel" @default.
- Q91205714 description "наукова стаття, опублікована 6 листопада 2019" @default.
- Q91205714 name "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 name "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 type Item @default.
- Q91205714 label "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 label "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 prefLabel "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 prefLabel "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 P1433 Q91205714-4935DD25-2EB1-4653-BDAF-9A9756DFDB8D @default.
- Q91205714 P1476 Q91205714-7CB6AFE2-A020-4580-BDEB-E5BFB2196ECA @default.
- Q91205714 P2093 Q91205714-1DFCB50B-F841-4D40-ACCA-960EEBB3A016 @default.
- Q91205714 P2093 Q91205714-B26720EB-9893-45DE-AE72-5D0F32D6967E @default.
- Q91205714 P304 Q91205714-9AC5143E-9072-42E7-9169-B2A6ADD22AD9 @default.
- Q91205714 P31 Q91205714-DF6FC473-9EDE-4BB3-BE9F-1CD6703419AF @default.
- Q91205714 P356 Q91205714-3C13A3EF-C155-42D8-A5EB-DE34B789FE93 @default.
- Q91205714 P478 Q91205714-8D516BDD-300F-4C01-A821-D47FD62365D0 @default.
- Q91205714 P50 Q91205714-2A076DB3-3979-454B-A34E-925BC4FD315C @default.
- Q91205714 P50 Q91205714-4D4FA185-3422-4F02-8E40-520366313963 @default.
- Q91205714 P577 Q91205714-BB834F38-E4C2-46BD-BF1C-58A43A7F5C5A @default.
- Q91205714 P698 Q91205714-DB6BB062-360C-4AF9-8548-B9ADB2CDE27B @default.
- Q91205714 P921 Q91205714-324FD220-E62A-4C5E-87CB-4C52E71D0C16 @default.
- Q91205714 P356 J.IJPHARM.2019.118729 @default.
- Q91205714 P698 31705975 @default.
- Q91205714 P1433 Q6051539 @default.
- Q91205714 P1476 "Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells" @default.
- Q91205714 P2093 "Jaleh Barar" @default.
- Q91205714 P2093 "Somayeh Vandghanooni" @default.
- Q91205714 P304 "118729" @default.
- Q91205714 P31 Q13442814 @default.
- Q91205714 P356 "10.1016/J.IJPHARM.2019.118729" @default.
- Q91205714 P478 "573" @default.
- Q91205714 P50 Q38323928 @default.
- Q91205714 P50 Q59425601 @default.
- Q91205714 P577 "2019-11-06T00:00:00Z" @default.
- Q91205714 P698 "31705975" @default.
- Q91205714 P921 Q172341 @default.